Alpha1-adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213)

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Satoshi TatemichiNobuo Shibata

Abstract

The selectivity of silodosin (KMD-3213), an antagonist of alpha(1)-adrenoceptor (AR), to the subtypes (alpha(1A)-, alpha(1B)- and alpha(1D)-ARs) was examined by a receptor-binding study and a functional pharmacological study, and we compared its subtype-selectivity with those of other alpha(1)-AR antagonists. In the receptor-binding study, a replacement experiment using [(3)H]-prazosin was conducted using the membrane fraction of mouse-derived LM (tk-) cells in which each of three human alpha(1)-AR subtypes was expressed. In the functional pharmacological study, the following isolated tissues were used as representative organs with high distribution densities of alpha(1)-AR subtypes (alpha(1A)-AR: rabbit prostate, urethra and bladder trigone; alpha(1B)-AR: rat spleen; alpha(1D)-AR: rat thoracic aorta). Using the Magnus method, we studied the inhibitory effect of silodosin on noradrenaline-induced contraction, and compared it with those of tamsulosin hydrochloride, naftopidil and prazosin hydrochloride. Silodosin showed higher selectivity for the alpha(1A)-AR subtype than tamsulosin hydrochloride, naftopidil or prazosin hydrochloride (affinity was highest for tamsulosin hydrochloride, followed by silodosin, prazosin hydrochlorid...Continue Reading

References

Jan 1, 1990·British Journal of Pharmacology·I MuramatsuM Oshita
Jun 1, 1994·Trends in Pharmacological Sciences·A P FordD E Clarke
Aug 1, 1995·Journal of Autonomic Pharmacology·Y HiraokaI Muramatsu
Mar 1, 1997·Naunyn-Schmiedeberg's Archives of Pharmacology·N TaniguchiK Kawabe
Jul 7, 1999·European Urology·S Z Langer
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD

❮ Previous
Next ❯

Citations

Feb 25, 2014·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·A DescazeaudP Coloby
Apr 20, 2014·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Nadir I OsmanChristopher R Chapple
Dec 6, 2012·Canadian Journal of Physiology and Pharmacology·Ding ZhaoLei-Ming Ren
Dec 1, 2010·Drug Design, Development and Therapy·Maxime Rossi, Thierry Roumeguère
Jul 15, 2011·Clinical Interventions in Aging·Masaki YoshidaKazuki Kawabe
Aug 24, 2012·International Urology and Nephrology·Yuanshan CuiYong Zhang
Nov 29, 2007·Expert Opinion on Investigational Drugs·Masaki YoshidaKazuki Kawabe
Dec 21, 2012·International Journal of Urology : Official Journal of the Japanese Urological Association·Toshiro ShirakawaMasato Fujisawa
Jan 29, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Teruhiko YokoyamaAtsushi Sone
Aug 26, 2010·International Journal of Urology : Official Journal of the Japanese Urological Association·Hideshi MiyakitaShuichi Yanada
Jul 16, 2016·International Journal of Urology : Official Journal of the Japanese Urological Association·Kimio SugayaHideyuki Yamamoto
Jul 5, 2016·Expert Opinion on Drug Metabolism & Toxicology·Denise Kreutzwiser, Alice Tseng
Aug 1, 2016·The Urologic Clinics of North America·Herbert Lepor
Apr 4, 2018·Current Opinion in Urology·Eu Chang HwangJae H Jung
Dec 12, 2012·Asian Journal of Andrology·Hui DingZhi-Ping Wang
Sep 8, 2020·Drugs & Aging·Giulia RivasiAndrea Ungar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.